There is a higher expression of WBP2 in hepatocellular carcinoma cells than in normal liver cells, and downregulation of WBP2 blocks the activation of the Wnt/β-catenin signaling pathway (Gao et al., 2020). The gene discussed is WBP2; the disease is hepatocellular carcinoma.